However, the model predicts that T2D remission does not necessarily require β-cell mass to be recovered (Figure 4E), where improved insulin sensitivity (Figure 4D) and increased β-cell function (Figure 4F) could be sufficient. The gene discussed is INS; the disease is type 2 diabetes mellitus.